Trivascular Snags $30M

Santa Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates, Delphi Ventures, MPM Capital, and Kearny Venture Partners, all existing investors in the firm. The company said the new funding round will go towards its operations and infrastructure. More information »